Extending anti-clotting treatment after distal deep vein thrombosis could reduce further clot risk
Bloating common issue among Americans, study reports
23 November 2022Volunteering and caring for grandchildren protects from loneliness for over 50s, study shows
24 November 2022Extending anti-clotting treatment after distal deep vein thrombosis could reduce further clot risk
Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.
